Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05945823
What this trial is testing

Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal CancerEsophageal AdenocarcinomaEsophageal Squamous Cell Cancer+2 more
Taiho Oncology, Inc. 53
Testing effectiveness (Phase 2)Looking for participantsNCT03539822
What this trial is testing

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

Who this might be right for
Gastric CancerEsophageal AdenocarcinomaHepatocellular Carcinoma+1 more
Anwaar Saeed 117
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00448760
What this trial is testing

Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery

Who this might be right for
Esophageal Cancer
University of Miami 29
Testing effectiveness (Phase 2)Ended earlyNCT01271322
What this trial is testing

Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)

Who this might be right for
Adenocarcinomas of the Esophagogastric Junction
National Center for Tumor Diseases, Heidelberg
Testing effectiveness (Phase 2)Study completedNCT00107341
What this trial is testing

Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction

Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 37
Not applicableStudy completedNCT06030180
What this trial is testing

CLUE: CLinical Utility Study of EsoGuard

Who this might be right for
Barrett EsophagusBarretts Esophagus With DysplasiaEsophagus Adenocarcinoma
Lucid Diagnostics, Inc. 566
Testing effectiveness (Phase 2)UnknownNCT05974059
What this trial is testing

Cadonilimab Combined With CapeOX Regimen in Perioperative Treatment of Resectable Locally Advanced Gastric Cancer

Who this might be right for
Locally Advanced Unresectable Gastric Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603375
What this trial is testing

Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma

Who this might be right for
Esophageal Adenocarcinoma
Duke University 60
Not applicableUnknownNCT03468244
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms

Who this might be right for
Advanced Esophageal Squamous CarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+1 more
Changhai Hospital 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT06680622
What this trial is testing

Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy

Who this might be right for
Metastatic Gastro-esophageal Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 126
Testing effectiveness (Phase 2)Looking for participantsNCT07222657
What this trial is testing

Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Cancer
Case Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT05568095
What this trial is testing

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

Who this might be right for
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Arcus Biosciences, Inc. 1,040
Not applicableNot Yet RecruitingNCT07800754
What this trial is testing

A Study in Greece Observing How Patients With Stomach and Esophageal Cancer Are Diagnosed and Treated in Everyday Medical Practice

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 300
Not applicableNo Longer AvailableNCT04681248
What this trial is testing

Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors

Who this might be right for
Esophageal NeoplasmAdenocarcinoma of the Gastroesophageal JunctionGastroEsophageal Cancer+7 more
Leap Therapeutics, Inc.
Large-scale testing (Phase 3)Study completedNCT00020787
What this trial is testing

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 8
Not applicableNot Yet RecruitingNCT07439484
What this trial is testing

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial

Who this might be right for
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00002711
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT03641547
What this trial is testing

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

Who this might be right for
Oesophageal AdenocarcinomaSquamous Cell CarcinomaSolid Tumor
University of Oxford 36
Not applicableStudy completedNCT06381583
What this trial is testing

A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma

Who this might be right for
Esophagus CancerEsophageal Cancer StageEsophageal Cancer+18 more
City of Hope Medical Center 658
Next Page
20